J&J’s Approach To Sourcing Innovation: Closing The Networking Gap
Executive Summary
Johnson & Johnson is nearing the completion of its network of early-stage innovation centers. IN VIVO talks to Patrick Verheyen of the year-old London hub to see where innovation centers fit into the J&J plan, and to Jimmy Zhang of the company’s soon-to-launch Shanghai branch about the climate for innovation in China and the wider Asia-Pacific region.
You may also be interested in...
GSK Woes Raise Big Pharma R&D Question
GSK's various thwarted efforts to boost productivity through R&D revamps begs the question whether big pharma should be trying to do in-house discovery and early development at all.
Bioqube Takes The Reins At J&J Innovation's JLINX
The recently launched venture capital firm has partnered with J&J Innovation to manage its new European life sciences incubator. START-UP speaks with bioqube's managing partner Nico Vandervelpen.
Medtech 2014: M&A, IPOs Bounce Back As Industry Glimpses Future Business Models
Healthy market growth, the biggest ever M&A deal, a record number of billion-dollar takeovers, and the IPO market in impressive bounce-back…2014 was a year of superlatives for the global medtech industry. But with more expected of manufacturers while health care spending remains in the doldrums and demand for care rises, the long-term medtech winners will be those who can forecast how and where to make an impact on both costs and patient outcomes.